Use of buprenorphine in children with chronic pseudoobstruction syndrome: Case series and review of literature

Clinical Journal of Pain

Volumn 28, Issue 8, 2012, Pages 722-725

  Prapaitrakool, Sunisa ^a   Hollmann, Markus W ^a   Wartenberg, Hans Christian ^a   Preckel, Benedikt ^a   Brugger, Stefan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

pain management; pediatric; transdermal buprenorphine

Indexed keywords

BUPRENORPHINE; CODEINE; FENTANYL; MORPHINE; TRAMADOL;

CASE REPORT; CHILD; CHRONIC DISEASE; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; CHRONIC INTESTINAL PSEUDOOBSTRUCTION SYNDROME; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; HUMAN; INTESTINE PSEUDOOBSTRUCTION; MALE; PRIORITY JOURNAL; PRURITUS; REVIEW; SYMPTOM; TREATMENT OUTCOME;

ABDOMINAL PAIN; ANALGESICS, OPIOID; BUPRENORPHINE; CHILD; CHILD, PRESCHOOL; HUMANS; INTESTINAL PSEUDO-OBSTRUCTION; MALE; PAIN MEASUREMENT;

EID: 84865644779     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318243f609     Document Type: Review

References (27)

1. Dudley HA, Synclair IS, McLaren IF, et al. Intestinal pseudo-obstruction. J R Coll Surg Edinb. 1958;3:206-217.
2. Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant Proc. 2010;42:15-18.
3. Mousa H, Hyman PE, Cocjin J, et al. Long-term outcome of congenital intestinal pseudo-obstruction. Dig Dis Sci. 2001; 47:2298-2305.
4. Faure C, Goulet O, Ategbo S, et al. Chronic intestinal pseudo-obstruction syndrome: clinical analysis, outcome and prognosis in 105 children. Dig Dis Sci. 1999;44:953-959. (Pubitemid 29205606)
5. Sigurdsson L, Reyes J, Kocoshi SA, et al. Intestinal transplantation in children with chronic intestinal pseudo-obstruction. Gut. 1999;45:570-574. (Pubitemid 29447827)
6. Lindberg G, Iwarzon M, Tornblom H. Clinical features and long-term survival in chronic intestinal pseudo-obstruction and enteric dysmotility. Scan J Gastroenterol. 2009;44:692-699.
7. Vargas JH, Sachs P, Ament ME. Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 1988;7:323-332.
8. Hyman PE. Chronic intestinal pseudo-obstruction in childhood: progress in diagnosis and treatment. Scand J Gastro-enterol. 1995;213(suppl):39-46.
9. Pironi L, Spinucci G, Paganelli F, et al. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. Transplant Proc. 2004;36:659-661. (Pubitemid 38534353)
10. Radbruch L, Sabatowski R, Loick G, et al. Constipation and the use of laxatives: a comparison between trans-dermal fentanyl and oral morphine. Palliat Med. 2000;14: 111-119. (Pubitemid 30198020)
11. Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice\a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin. 2005;21:1147-1156. (Pubitemid 41140716)
12. Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther. 2003;25:150-168. (Pubitemid 36206743)
13. Poulain P, Denier W, Douma J, et al. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. J Pain Symptom Manage. 2008;36:117-125. (Pubitemid 352010492)
14. Muriel C, Failde I, Mico JA, et al. Effectiveness and tolerability of the buprenorphinetransdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther. 2005;27:451-462. (Pubitemid 40732652)
15. Sorge J, Sittl R. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2004;26: 1808-1820. (Pubitemid 40089494)
16. Attina G, Ruggiero A, Maurizi P, et al. Transdermal buprenorphine in children with cancer-related pain. Pediatr Blood Cancer. 2009;52:125-127.
17. Michel E, Anderson BJ, Zernikow B, et al. Buprenorphine TTS for children\a review of the drug's clinical pharmacology. Paediatr Anaesth. 2011;21:280-290.
18. Dahan A. Opioid-induced respiratory effects: new data on buprenorphine. Palliat Med. 2006;20:s3-s8. (Pubitemid 43871328)
19. Dahan A, Yassen A, Bijl H, et al. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. Br J Anaesth. 2005;94:825-834. (Pubitemid 40754001)
20. Likar R, Kayser H, Sittl R. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther. 2006;28:943-952. (Pubitemid 44062699)
21. US Food and Drug Administration. Antidepressant use in children, adolescents, and adults. 2-5-2007. Available at: http://www.fda.gov/Drugs/ DrugSafety/InformationbyDrugClass/UCM096273. Assessed August 23, 2010.
22. Huertas-Ceballos A, Logan S, Bennett C, et al. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev. 2008;23:CD003017.
23. Bahar RJ, Collins BS, Steinmetz B, et al. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152:685-689.
24. Saps M, Youssef N, Miranda A, et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009; 137:1261-1269.
25. Lee DO, Steingard RJ, Cesena M, et al. Behavioral side effects of gabapentin in children. Epilepsia. 1996;37:87-90. (Pubitemid 26021582)
26. Likar RM, Sittl RM. Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies. [Report]. Anesth Analg. 2005;100:781-785.
27. Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev. 2006;32:304-315. (Pubitemid 44502005)